Docgo vs Viemed Healthcare
Docgo is the larger business, with $322m of revenue in fiscal 2025 against $270m for Viemed Healthcare (1.2 times as much). Viemed Healthcare grew faster (20.5% against -47.7%). Viemed Healthcare kept more of each dollar of sales as profit: a net margin of 5.5% against -56.6%.
| Latest fiscal year | DocgoDCGO, 2025 | Viemed HealthcareVMD, 2025 |
|---|---|---|
| Revenue | $322m | $270m |
| Revenue growth | -47.7% | 20.5% |
| Net income | −$182m | $14.9m |
| Operating margin | — | 8.5% |
| Net margin | -56.6% | 5.5% |
| Return on equity | -78.5% | 10.9% |
| Free cash flow | $29.9m | $11.9m |
| Cash | $51.0m | $13.5m |
| Total debt | $287,323 | $12.4m |
| Debt to equity | — | 8.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.8m | $13.2m |
| Employees | 3,600 | — |
| Market value | $25.6m | $357m |
| Price vs our value range | — | Above our value range |
| Moat score | 18 (Weak) | 62 (Moderate) |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 9 sales |